- Home
- FSS vs RARE Comparison
FSS vs RARE Comparison
Compare FSS & RARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSS
- RARE
- Stock Information
- Founded
- FSS 1901
- RARE 2010
- Country
- FSS United States
- RARE United States
- Employees
- FSS N/A
- RARE N/A
- Industry
- FSS Auto Manufacturing
- RARE Biotechnology: Pharmaceutical Preparations
- Sector
- FSS Consumer Discretionary
- RARE Health Care
- Exchange
- FSS Nasdaq
- RARE Nasdaq
- Market Cap
- FSS 5.7B
- RARE 5.2B
- IPO Year
- FSS N/A
- RARE 2014
- Fundamental
- Price
- FSS $99.10
- RARE $40.89
- Analyst Decision
- FSS Buy
- RARE Strong Buy
- Analyst Count
- FSS 3
- RARE 15
- Target Price
- FSS $100.00
- RARE $92.00
- AVG Volume (30 Days)
- FSS 396.2K
- RARE 1.0M
- Earning Date
- FSS 02-25-2025
- RARE 02-13-2025
- Dividend Yield
- FSS 0.48%
- RARE N/A
- EPS Growth
- FSS 44.95
- RARE N/A
- EPS
- FSS 3.45
- RARE N/A
- Revenue
- FSS $1,837,900,000.00
- RARE $522,745,000.00
- Revenue This Year
- FSS $9.71
- RARE $26.70
- Revenue Next Year
- FSS $7.30
- RARE $19.02
- P/E Ratio
- FSS $28.18
- RARE N/A
- Revenue Growth
- FSS 10.33
- RARE 27.44
- 52 Week Low
- FSS $74.40
- RARE $37.02
- 52 Week High
- FSS $102.18
- RARE $60.37
- Technical
- Relative Strength Index (RSI)
- FSS 62.37
- RARE 40.43
- Support Level
- FSS $95.13
- RARE $39.99
- Resistance Level
- FSS $99.11
- RARE $44.52
- Average True Range (ATR)
- FSS 2.78
- RARE 2.18
- MACD
- FSS 0.59
- RARE -0.03
- Stochastic Oscillator
- FSS 92.77
- RARE 17.75
About FSS Federal Signal Corporation
Federal Signal Corp designs and manufactures products and integrated solutions for municipal, governmental, industrial, and airport customers. It operates in the segments of Environmental Solutions Group and the Safety and Security Systems Group. The Environmental Solutions group manufactures and supplies street sweeper vehicles, sewer cleaner and vacuum loader trucks, hydro-excavation trucks, high-performance water blasting equipment, dump truck bodies, and trailers. The Safety and Security Systems Group offers comprehensive systems and products such as campus and community alerting, emergency vehicles, first responder interoperable communications, and others. The company generates a majority of its revenue from the Environmental Solutions Group segment.
About RARE Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi, and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.